Priya Sachdeva

Stock Analyst at UBS

(n/a)

# 4,480

Out of 4,876 analysts

4

Total ratings

n/a

Success rate

-14.4%

Average return

Main Sectors:

Top Industries:

Medical Devices

Stocks Rated by Priya Sachdeva

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	PEN Penumbra	Maintains: Buy	$320 → $330	$256.43	+28.69%	3	Apr 24, 2025
	NPCE NeuroPace	Initiates: Buy	$17	$10.71	+58.73%	1	Jan 21, 2025

Penumbra

Apr 24, 2025

Maintains: Buy

Price Target: $320 → $330

Current: $256.43

Upside: +28.69%

NeuroPace

Jan 21, 2025

Initiates: Buy

Price Target: $17

Current: $10.71

Upside: +58.73%